“the FDA agreed to look at a pivotal clinical trial and consider that for final approval after the first approval so it will be expanded label.”

Does this mean CYDY can/will attempt to use the most recent Mono trial of 550+ patients to file for a label extension? Or does CYDY still need to conduct another 48 week, costly Mono trial and then file for label extension?